JORDAN NAIL: Open Payments
NPI 1033852629 · BIRMINGHAM, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$226 in 12 payments from 7 companies in 2025. Trend: 2023 $0 · 2024 $19 · 2025 $226
Food & beverage: $226
| Company | Payments | Amount |
|---|---|---|
| Caris MPI, Inc. | 4 | $69 |
| AstraZeneca Pharmaceuticals LP | 2 | $38 |
| Eisai Inc. | 2 | $33 |
| JAZZ PHARMACEUTICALS INC. | 1 | $29 |
| Tempus AI, Inc | 1 | $22 |
| Ipsen Biopharmaceuticals, Inc | 1 | $21 |
| BeOne Medicines USA, Inc. | 1 | $14 |
Products named: MI CANCER SEEK, Lenvima, ZEPZELCA, XT CDX, Onivyde, IMFINZI, BRUKINSA.
Industry payments across AL — which companies pay providers there.
